Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life-Reference-Cited by-同舟云学术

Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life

Published:2001-11 Issue:4 Volume:51 Page:988-993
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Kupelian Patrick A,Reddy Chandana A,Klein Eric A,Willoughby Twyla R

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference18 articles.

1. Toward optimal external-beam fractionation for prostate cancer;Brenner;Int J Radiat Oncol Biol Phys,2000

2. Fractionation and protraction for radiotherapy of prostate carcinoma;Brenner;Int J Radiat Oncol Biol Phys,1999

3. What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy;Duchesne;Int J Radiat Oncol Biol Phys,1999

4. Short-course intensity-modulated radiotherapy for localized prostate cancer with daily transabdominal ultrasound localization of the prostate gland;Mohan;Int J Radiat Oncol Biol Phys,2000

5. Indications for excluding the seminal vesicles when treating clinically localized prostatic adenocarcinoma with radiotherapy alone;Katcher;Int J Radiat Oncol Biol Phys,1997

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypofractionated versus conventional fractionation external beam radiotherapy in intermediate and high risk localized prostate cancer;Discover Oncology;2024-02-02

2. Hypofractionated Versus Conventional Fractionation External Beam Radiotherapy in Intermediate and High Risk Localized Prostate Cancer;2023-10-17

3. Moderate hypofractionated helical tomotherapy for older patients with localized prostate cancer: long-term outcomes of a phase I–II trial;Radiology and Oncology;2022-03-28

4. A Prospective Multi-Institutional Phase I/II Trial of Step-Wise Dose-per-Fraction Escalation in Low and Intermediate Risk Prostate Cancer;Practical Radiation Oncology;2020-09

5. Hypofractionated radiotherapy versus conventional radiotherapy in patients with intermediate- to high-risk localized prostate cancer: a meta-analysis of randomized controlled trials;BMC Cancer;2019-11-08